Reprogramming Age: Jacob Kimmel on How NewLimit Uses AI to Extend Healthspans

Healthcare in Your Pocket: Counsel Health’s Muthu Alagappan on Messaging-Based Care and the Future of Access

Blending his experience as a physician and AI researcher, Muthu Alagappan founded Counsel Health on the belief that healthcare should work like the rest of modern life: mobile, immediate, and on demand. Counsel's AI-powered, messaging-based platform augments physician capacity, expands patient access, and reimagines care delivery for a digital-first world.

Spanning Every Surface: Google Cloud’s Aashima Gupta on AI, Access, and Adaptive Healthcare

Leading Google Cloud’s evolution into a healthcare intelligence layer, Aashima Gupta discusses how agentic AI is transforming access and personalization across care touchpoints. She references partnerships like CVS Health alongside Google’s efforts to operationalize Gemini and DeepMind innovations into scalable tools for providers, payers, and innovators.

Medicare meets AI: Andrew Toy on How Clover Health Superpowers Clinicians and Enables Earlier Intervention

Reimagining the future of payers, Andrew explores what it means to be truly AI-native at Clover Health: connecting fragmented data for earlier intervention, creating an API-to-truth, and sidestepping bot-on-bot warfare. From positioning the doctor as the primary UI to balancing patient privacy with innovation, he brings a technologist’s perspective to the top of healthcare’s capital stack.

Reprogramming Age: Jacob Kimmel on How NewLimit Uses AI to Extend Healthspans

Leveraging a career focused on the biology of aging, Jacob Kimmel explains how NewLimit uses advanced AI to navigate vast genetic combinations and prioritize experiments that reprogram cells to more youthful, functional states. With a large-scale data library, a small team, and a novel approach, NewLimit is developing therapies to enable longer, healthier lives.

At the Intersection: Jacob and Eli Berlin on How Terray Merges Chemistry and Compute to Drive Drug Discovery

Working at the intersection of chemistry, machine learning, and AI, Jacob and Eli Berlin discuss how Terray is transforming drug discovery. By building and testing small molecules at a massive scale, Terray accelerates candidate discovery in uncharted chemical space and redefines what an AI-native biotech can achieve.